4.5 Article

Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 18, Issue 7, Pages 840-U120

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2067

Keywords

-

Funding

  1. Institut National de la Sante et de la Recherche Medicale (INSERM) AVENIR
  2. Agence nationale de la recherche (ANR) GENOPAT [P007942]
  3. Association Francaise contre les Myopathies (AFM) [MNM1-12982]
  4. UPMC
  5. US National Institutes of Health (NIH) [P30 AR057220]
  6. Muscular Dystrophy Center Core Laboratories
  7. Ministere de l'enseignement superieur et de la recherche
  8. University of Strasbourg
  9. Ministry of Health, Labour and Welfare, Japan
  10. Grants-in-Aid for Scientific Research [23591245] Funding Source: KAKEN

Ask authors/readers for more resources

Myotonic dystrophy is an RNA gain-of-function disease caused by expanded CUG or CCUG repeats, which sequester the RNA binding protein MBNL1. Here we describe a newly discovered function for MBNL1 as a regulator of pre-miR-1 biogenesis and find that miR-1 processing is altered in heart samples from people with myotonic dystrophy. MBNL1 binds to a UGC motif located within the loop of pre-miR-1 and competes for the binding of LIN28, which promotes pre-miR-1 uridylation by ZCCHC11 (TUT4) and blocks Dicer processing. As a consequence of miR-1 loss, expression of GJA1 (connexin 43) and CACNA1C (Cav1.2), which are targets of miR-1, is increased in both DM1- and DM2-affected hearts. CACNA1C and GJA1 encode the main calcium-and gap-junction channels in heart, respectively, and we propose that their misregulation may contribute to the cardiac dysfunctions observed in affected persons.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available